Phase I/II Study Demonstrates Good Efficacy for Gastric Cancer
April 23rd 2020Shuichi Hironaka, MD, PhD, discusses the efficacy of a phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line treatment of patients with advanced gastric cancer during the 2020 Gastrointestinal Cancers Symposium.
Watch
Evaluating the Feasibility of Liso-cel Administration in the Outpatient Setting
April 22nd 2020Carlos R. Bachier, MD, discusses how an analysis of 3 clinical trials evaluating the efficacy of lisocabtagene maraleucel demonstrated the feasibility of outpatient administration of chimeric antigen receptor T-cell therapy.
Watch
Exploring Subsets of Patients With Mantle Cell Lymphoma
April 20th 2020Sonali M. Smith, MD, discusses the current understanding of mantle cell lymphoma and how this understanding has evolved over recent years to understand different subsets of the disease that may require different frontline treatment for patients.
Watch